First-of-Its-Kind Diabetic Retinopathy Treatment Approved Roche’s Susvimo is now the first and only FDA-approved continuous ...

Clearance of ASC50 paves the way for a Phase I trial in patients with mild-to-moderate plaque psoriasis.

Deal includes VG-3927, a first-in-class TREM2 agonist aimed at advancing next-generation Alzheimer disease therapies.

Lilly is also developing oral therapies for its gastroenterology pipeline.

The film tells the story of a family impacted by the disease and shares the importance of checking to make sure that children ...

Results from the Phase II WILLOW trial show that enpatoran achieved a statistically significant dose-response and clinically ...

Leandro Boer, MD, PhD, VP, US general medicines, Amgen, discusses the company's nationwide push to reduce cardiovascular risk ...

Prioritizing deeper customer insights helps life sciences marketers understand how to engage their HCP audiences effectively ...

Positive feedback was based on Phase III AQUILA trial results, which showed a significant clinical benefit with Darzalex Faspro in patients with high-risk smoldering multiple myeloma.

Under terms of the deal, Pfizer will gain rights to develop, manufacture, and commercialize SSGJ-707 outside of China.

Previously granted Emergency Use Authorization, Nuvaxovid is now available for individuals over 12 years of age.

The ability to predict side effects such as nausea before starting treatment represents a paradigm shift in precision ...